NFAT activating protein with ITAM motif 1 (NFAM1)

NFAT activating protein with ITAM motif 1 (NFAM1) is a type I transmembrane receptor in the immunoglobulin superfamily, predominantly expressed in cells of the innate and adaptive immune system, notably B cells and monocytes[1][3][4]. NFAM1 contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain, which—when crosslinked—initiates phosphorylation events leading to recruitment of ZAP-70/Syk kinases, influx of calcium, and subsequent activation of the calcineurin/NFAT signaling cascade[4][5][6]. This signaling results in the upregulation of multiple pro-inflammatory cytokines and chemokines, including TNF-α, IL-2, IL-13, IL-6, IL-12, MIP-1α, and MIP-1β[3][5]. NFAM1 plays a key regulatory role in B cell signaling and development and modulates monocyte activation, linking it to both adaptive and innate immune responses[3][6]. Increased NFAM1 expression is associated with certain immune-mediated conditions, and it is being evaluated as a potential therapeutic target for limiting pathological immune responses without producing broad immunosuppression[3]. No approved drugs are known to target NFAM1 directly, though inhibitors of the downstream NFAT pathway (e.g., cyclosporine A, tacrolimus) affect NFAM1-mediated signaling indirectly[3]. Potential safety concerns with targeting NFAM1 include immune dysregulation and increased infection risk, similar to general NFAT pathway inhibition[3][4].

Other names

NFAT activation molecule 1CNAIPCalcineurin/NFAT-activating ITAM-containing proteinNFAM1NFAT-activating protein with ITAM motif 1

Activation of calcineurin/NFAT signaling pathway - Initiates phosphorylation cascades (via ITAM domain) upon crosslinking, leading to ZAP-70/Syk recruitment and NFAT activation